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Summary It has been previously demonstrated that cisplatin induces apoptosis in the CH1 human ovarian
carcinoma cell line. This study demonstrates that two novel platinum (Pt) analogues JM149 and JM335, which
are the cis and trans geometry respectively of ammine(cyclohexylamine)dihydroxodichloroPt(IV), initiate
apoptosis in this cell line at physiologically relevant concentrations (IC50 values 2 h drug exposure were
35.3 gM for JM149 and 18.7 tM for JM335). While at equimolar drug concentrations there was a 2-fold higher
level of total platinum-DNA adducts following exposure to JM335 vs JM149, at equitoxic concentrations,
levels were similar (80 vs 70 pmol Pt mg - DNA respectively). Following a 2 h incubation with 2 x IC50 Of
both drugs, cells rounded up and detached in a time-dependent manner but with the kinetics of apoptosis being
more rapid for JM335. The majority of detached cells exhibited morphology associated with apoptosis which
was further supported by the presence of a 50 kb fragment detected in DNA lysates prepared from these cells.
JM149 induced apoptosis across a range of concentrations (2 x, 5 x and 1Ox IC50) with a 50 kb DNA
fragment being detected at all concentrations. However, in marked contrast to this, JM335 failed to cause
apoptosis at 10 x IC50, the detached cells neither displaying apoptotic morphology nor a detectable 50 kb DNA
fragment. Moreover, these detached cells showed evidence of extensive vesiculation while the DNA remained
normal in appearance and thus appeared to have died by a non-apoptotic mode. Apoptosis also appeared to be
induced to a lesser extent at 5 x IC50 of JM335 as demonstrated by a less intense 50 kb fragment compared
with that seen at 2 x IC50. The main cell cycle effect of these drugs (at 2 x IC50) was a slowdown in S-phase
traverse during which most but not all of the apoptosis appeared to occur. However, at 5 x IC50 ofJM335 cells
appeared frozen in all phases of the cell cycle with little progress from GI to S accompanied by a build-up of
cells in G2 indicative of a G2/M block. This difference in cell cycle effect may account for the reduced level of
apoptosis at this concentration and a failure to engage apoptosis at higher concentrations. These data suggest
that the nature of the platinum drug (and consequently, the nature of resultant DNA damage) may have
important implications in determining the rate and mechanism of cell death in this cell line. The cell death
effects observed with the trans complex JM335 may correlate with the induction of DNA single-strand breaks
in this cell line.
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Apoptosis is a biological mechanism by which cells undergo
programmed cell death. Many chemotherapeutic agents of
disparate mechanisms of action engage this conserved cellular
response, including etoposide (Liu, 1989), camptothecin
(Kaufmann, 1989), dexamethasone (Cohen et al., 1992;
Wood et al., 1994) and taxol (Milas et al., 1995). It is
thought that apoptosis may be the major mechanism through
which drugs mediate their cytotoxic effects (Hickman, 1992;
Kerr et al., 1994). Furthermore, it has been proposed that
tumour sensitivity and resistance to such drugs (and thus
clinical outcome) may, at least in part, be attributable to the
degree of activation of a genetic programme for cell death
(Dive and Hickman, 1991).
Cisplatin has been shown to induce apoptosis in a number
of different cell lines including Chinese hamster ovarian cells,
immature rat thymocytes, rat hepatoma cells and L1210
murine leukaemic cells (Barry et al., 1990; Sorenson et al.,
1990; Evans and Dive, 1993; Ormerod et al., 1994a). In recent
studies, the kinetics of cisplatin-induced apoptosis have been
measured in vivo in mammary and ovarian adenocarcinomas
in rodents (Meyn et al., 1995). We have demonstrated that
cisplatin induced apoptosis in three human ovarian
carcinoma cell lines, the CH1, the acquired resistant
CHlcisR and the intrinsically resistant SKOV-3 without
concomitant internucleosomal cleavage (Ormerod et al.,
1994b; Ormerod et al., 1996). The resistance factors for
CHlcisR and SKOV-3 following a 2 h exposure to cisplatin
were 3- and 13-fold respectively (O'Neill et al., 1995) with
equitoxic concentrations of drug required to induce similar
levels of apoptosis (Ormerod et al., 1996). Furthermore, we
observed that apoptosis was the major mode of cell death,
occurring at concentrations ranging from the physiologically
relevant ICso (the dose required to give 50% growth
inhibition) to 10 times this dose. In the data presented here
we have extended these studies to new platinum drugs. The
work centres on two novel platinum compounds, JM149 and
JM335, which are cis and trans analogues respectively
of ammine(cyclohexylamine)dihydroxodichloroplatinum(IV).
These drugs have been synthesised as part of a drug
discovery programme aimed at identifying more effective
platinum-based anti-cancer drugs. Recent studies have shown
that JM335 exhibited a different pattern of cross-resistance
from JM149 in an in vitro panel of sensitive and resistant cell
lines (Kelland et al., 1994). Furthermore, preliminary DNA
binding studies in the SKOV-3 cell line demonstrated that, at
equimolar concentrations, more Pt was bound to DNA with
JM335 than with JM149. Moreover, JM335 like cisplatin also
formed interstrand cross-links (ISC) which are thought to be
the most cytotoxic ofPt/DNA lesions formed (Zwelling et al.,
1981; Hansson et al., 1988), while JM149 did not. In contrast
to this, in the CHI cell line, while JM149 initiated very low
levels of ISC formation, these were undetectable following
equimolar concentrations of JM335, which instead caused
DNA strand breaks (Mellish et al., 1995). We have assessed
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this Pt IV cis/trans pair of Pt analogues for their ability to
induce apoptosis and their effects on the cell cycle in CHI
cells.
Materials and methods
JM149 and JM335 (Figure 1) were synthesised by and
obtained from The Johnson Matthey Technology Centre
(Reading, Berkshire, UK). Dulbecco's modified Eagle
medium (DMEM), trypsin, phenol and cell culture supple-
ments were purchased from Gibco/BRL (Uxbridge, Mid-
dlesex, UK). Agarose (ultra pure), fluorescein diacetate
(FDA), propidium iodide(PI), pulse field molecular weight
markers and all other reagent chemicals were purchased from
Sigma Chemical Co. Ltd. (Poole, Dorset, UK).
Cell culture and cytotoxicity
The CH1 human ovarian carcinoma was cultured as a
monolayer in DMEM supplemented with 10% heat-
inactivated fetal calf serum (FCS), MEM non-essential
amino acids, 2 mM glutamine, 5 pg ml-' insulin,
0.4 pg ml-' hydrocortisone, 2.5 pg ml-1 amphotericin and
50 ng ml-' gentamicin. JM149 and JM335 were dissolved in
sterile 0.9% sodium chloride solution and ICs0 values
determined at 96 h following a 2 h exposure to drug by the
sulphorhodamine B assay (SRB) as previously described
(Kelland et al., 1992). The rate of cellular detachment was
measured over a 72 h period following a 2 h incubation with
2 x and 5 x the IC50 of both drugs.
Measurement ofplatinum bound to DNA
Following a 2 h incubation with equimolar concentrations of
JM149 and JM335, DNA was extracted using the phenol
method as previously described (O'Neill et al., 1995). Dried
DNA pellets were dissolved overnight at 37°C in 0.2% nitric
acid and platinum content measured by flameless atomic
absorption spectroscopy (FAAS) using a Perkin Elmer
1100B/HGA 700. DNA content was measured using the
Burton assay, a colorimetric method which quantitates 2'-
deoxyribose units (Burton, 1956). Results were expressed as
pmols ofplatinum (Pt) per mg of DNA. The DNA extraction
efficiency was an average of 90 pg± 10 per 107 cells.
Microscopy
Cells were exposed to 2 x and 10 x IC50 concentrations of
JM149 and JM335 for 2 h and collected 24 h later. Detached
cells were harvested from the culture medium by centrifuga-
tion with attached cells being removed by incubation with
0.2% trypsin for 5 min before collection. Cell pellets were
washed in phosphate-buffered saline (PBS) and fixed in 2%
glutaraldehyde in 0.05 M PBS, 0.05 M sucrose, pH 7.3, for
2 h at room temperature. Following this, pellets were post-
fixed in 1% osmium tetroxide, dehydrated through a graded
series ofethanols, infiltrated and embedded in epon. For light
microscopy, 1 pm sections were cut and stained with
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toluidine blue. For electron microscopy, 0.1 pum sections
were picked up on copper grids and double stained with
uranyl acetate and lead citrate and viewed with a Philips
CM1O using 80 kv accelerating voltage.
Flow cytometry
For cell cycle analysis, cultures were exposed to 2 x and
5x IC50 concentrations of JM149 and JM335 for 2 h and
attached cells washed, incubated with trypsin as above and
collected by centrifugation at 0, 2, 5, 16 and 24 h following
removal of drug. Cell pellets were resuspended in 200 pul ice-
cold PBS and fixed for at least 30 min in 1.8 ml ice-cold 70%
ethanol. The fixed cells were centrifuged and the pellets
resuspended in 800 p1 PBS, 100 pl (1 mg ml-1) RNAase and
100 ptl of PI (200 pg ml-1) and left to incubate at 37°C for
30 min. Flow cytometry was carried out on a Coulter Elite
equipped with a Spectra-physics argon-ion laser with an
output of 200 mW at 488 nm. Data from 2 x 104 cells were
analysed with forward and orthogonally scattered light and
red fluorescence (peak and integrated area) recorded. Pulse
shape analysis was performed to eliminate any cell clumps
and data were gated on light scatter before recording a
histogram of red (PI-DNA) fluorescence (Ormerod et al.,
1994a).
Viability studies
Cell viability was estimated by flow cytometry using the
fluorescein diacetate/propidium iodide (FDA/PI) method
(Ormerod, 1994); the cells were incubated in medium at
room temperature for 10 min with 50 ng ml- FDA. PI at
5 pg ml-' was added and green and red fluorescence recorded
in a flow cytometer using an argon-ion laser tuned to 488 nm.
Green-positive, red-negative cells were scored as viable,
green-negative, red-positive cells as dead.
DNA gel electrophoresis
Cells were incubated with 2 x, 5 x and 10 x IC50 of JM149
and JM335 with attached and detached cells collected 24 h
later by centrifugation. Cell pellets (approximately 5 x 105
per 50 pl) were incubated for 1 h at 37°C in a lysis buffer
[200 mM Tris, 100 mM EDTA, 2% sodium dodecyl sulphate
(SDS)] containing 1 mg ml-' proteinase K final concentra-
tion. An aliquot of 10 pl of a 1 mg ml - solution of
RNAase per 50 pl of sample was added and incubation
continued for a further hour. Aliquots of cell lysate were
added directly to the gel, the wells being sealed with 1% low
melting point agarose. Field inversion gel electrophoresis
(FIGE) was performed with 1 x TAE (40 mM Tris, 20 mM
sodium acetate and 1 mM EDTA) using a Bio Rad FIGE
Mapper. Horizontal gels were run for 20 h in 1 x TAE
buffer with a forward voltage of 10 V cm-' and reverse of
7 V cm-' with linear ramping T1= 1 s to T2= 12 s. The
temperature of the TAE buffer was controlled to 14°C using
a Bio Rad 1000 mini-chiller. Sigma Pulse Marker A
fragments 0.1-200 kb and S. cerevisiae fragments 225-
2200 kb were run with the samples.
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Results
Cytotoxicity
The cytotoxicity of both drugs was measured using the SRB
assay 96 h following a 2 h exposure to drug (Figure 2). The
IC50 s were 35.3+ 1.5 gM for JM149 and 18.7+8.4 gM for
JM335; this difference just attained statistical significance
(P=0.03). This gave an approximately 1.9-fold difference in
activity, similar to that seen in previous studies following
continuous exposure to drug for 96 h (Kelland et al., 1994).
Platinum bound to DNA
The amount of Pt bound to DNA was measured following a
2 h incubation with 25, 50 and 100 gM JM149 and JM335
(Figure 3). There was approximately twice as much Pt bound
to DNA following incubation with JM335 compared with
JM149. For example, incubation with 50 gM drug resulted in
50+2 pmol mg-' DNA for JM149 and 110.5
+35.5 pmol mg-' DNA for JM335 (P-value 0.04). How-
ever, at equitoxic concentrations (2 x IC50) total platinum
levels on DNA (i.e. inclusive of monofunctional and
bifunctional adducts) were similar for the two isomers;
JM149 at 70 ,M, 70 pmol mg-' DNA, JM335 at 37 gM,
80 pmol mg-' DNA.
Cell death induced by JM149 and JM335
The detachment of cells was measured after a 2 h incubation
with 2 x and 5 x IC50 of JM149 and JM335, both attached
and detached cells being counted at 0, 5, 16, 24, 48, and 72 h
following the removal of drug. The number of attached cells
remaining at each time point was calculated as a percentage
of cell number at time 0 (Figure 4a). Following exposure to
JM149 numbers ofattached cells continued to increase for up
to 24 h and 16 h after 2 x and 5 x the ICso respectively,
while no increase in the number of the attached cell
population was observed after incubation with either
concentration of JM335.
The number of detached cells was calculated as a
percentage of the total number of cells present at each time
point so as to take into account any increase in cell number
following removal of drug (Figure 4b). At equitoxic
concentrations of drug, JM335 initiated cellular detachment
at a much faster rate than JM149 which appeared to exhibit a
time lag for up to 15 h following removal of drug. By 24 h
following removal of drug, approximately 77% and 82%
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Figure 3 Platinum binding to DNA following a 2h exposure to
25, 50 and 100pM JM149 (U) and JM335 (A). Error bars
represent s.d. where n=3.
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Figure 2 Cytotoxicity ofJM149 (M) and JM335 (A) in the CHI
cell line following 2h drug exposure. Error bars represent s.d.
where n =3.
Figure 4 (a) Attached cells remaining as a percentage of cell
number at time 0 and (b) detached cells as a percentage of total
cell number at each time point following a 2h exposure to 2 x
(U) and 5 x (A) the IC50 of JM149 and 2 x(*) and 5 x (0) the
IC50 of JM335. Error bars represent s.d. where n =3.
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Figure 5 Light microscopy of CH1 cells harvested 24h following exposure to 2 x and 10 x the IC50 of drug. (a) Control untreated
attached cells. (b) Attached cells at 2 x JM149. (c) Attached cells at 2 x JM335. (d and e) Detached cells at 2 x JM149 and JM335.
(f and g) Detached cells at 10 x JM149 and JM335. Original magnification x 600, bar = 25gm.
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Mm= ,. =-4 'Arespectively of cells had detached following 2 x and 5 x IC50
JM335 compared with only 17% and 43% for JM149. The
majority of JM149-treated cells had detached by 72 h. The
combined total of attached and detached cells 24 h after
exposure to either drug at either concentration was similar
[e.g. JM149 (2 x IC50) 2.8 x 106 cells, (5 x IC50) 2.3 x 106 cells;
JM335 (2 x IC50) 2.4 x 106 cells, (5 x IC50) 2.6 x 106 cells].
Thus, although cell numbers increased with JM335, these
cells appeared to be dying and detaching immediately
following cell division whereas the majority of the JM149-
treated cells remained attached.
Morphology and viability ofattached and detached cells
The morphology of attached and detached cells was
examined by light and electron microscopy 24 h following a
2 h incubation with 2 x and 10 x IC50 of JM149 and JM335.
The attached cells remaining after incubation with 2 x IC50 of
JM149 showed no evidence of chromatin condensation
associated with apoptosis, with the chromatin remaining
similar in appearance to that of control untreated cells
(Figure 5a and b). On the other hand while the majority of
the attached cells remaining after 2 x IC50 of JM335 exhibited
normal morphology, there was evidence that some apoptosis
had taken place in that there were a small number of cells
showing evidence of chromatin condensation (arrowed on
Figure 5c). At 2 x IC50 of both drugs the majority of detached
cells exhibited the morphology consistent with apoptosis,
displaying the characterisatic condensation and fragmenta-
tion pattern of chromatin around the periphery of the
nucleus (Figure 5d and e). At 10 x IC50 of JM149, the
detached cells were again apoptotic in appearance (Figure 5f
and Figure 6a), however, in contrast to this, the detached
cells induced by the trans complex, JM335, at this
concentration did not exhibit morphology associated with
apoptosis (Figure 5g and Figure 6b). The chromatin was not
condensed and resembled that of the attached cells. More-
over, there was evidence of extensive vesiculation in these
cells which could be seen more clearly upon closer
examination by electron microscopy (Figure 6b). Cell
viability was estimated by measuring the number of cells
with intact plasma membranes by flow cytometry 24 h
following a 2 h incubation with both drugs. Across the
range of concentrations of both drugs the average percentage
of viable cells was 91% for the attached cells and between
35% and 64% for the detached cells (Table I).
DNA gel electrophoresis
FIGE was carried out on cell lysates prepared from attached
and detached cells harvested 24 h after a 2 h exposure to 2 x,
5 x and 10 x IC50 of JM149 and JM335. A fragment
approximately 50 kb in size, was detected in the detached
cells obtained with 2 x, 5 x and 10x IC50 of JM149. This
fragment was readily observable in the detached cells
following 2 x IC50 of JM335, was less apparent at 5 x IC50
but was not detectable at 10 x IC50 JM335 (Figure 7). This
fragment was also absent from the attached cells at all
concentrations of both drugs. Furthermore, internucleosomal
cleavage could not be detected in the cells undergoing
apoptosis (data not shown).
Cell cycle analysis
Flow cytometric analysis of the effects of 2 x and 5 x IC50 Of
JM149 and JM335 on the progression of cells through the
cell cycle was carried out on attached cells only. The DNA
histograms indicated that the main effect of both concentra-
tions of JM149 and 2 x IC50 of JM335 was a slowdown of
passage through S-phase (Figure 8) as evidenced by the
increase in the percentage of cells in this phase of the cell
cycle by 16 h and 24 h following removal of drug (Figure 9).
By 24 h, cells exposed to 2 x IC50 of JM335 and 5 x IC50 Of
JM149 had not progressed beyond early S-phase, while those
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exposed to 2XIC50 JM149 had progressed to late S-phase
(Figure 8). However, at 5 x IC50 of JM335 cells seemed
almost frozen in the cell cycle with little movement from G1
into S and this was accompanied by a build-up of cells in G2
representative of a G2/M block (Figure 9).
Figure 6 Electron micrographs ofdetached cells. (a) 10 x JM149
and (b) 10 x JM335. Original magnification: a x 5000; b x 9000.
(a) bar 2,um; (b) bar 4pgm.
Table I Percentage viability of attached and detached cells
measured 24 h following a 2 h incubation with JM149 and JM335
Percentage viability Percentage viability
IC50 ofattached cells ofdetached cells
JM149 x 2 99+0.0 41.2+1.4
x 5 88.5+ 10.4 43.3+6.2
x10 84.8+18.4 39.6+11.8
JM335 x 2 91.4+6.2 35.2+4.7
x 5 94.5+1.7 41.6+26
x 10 90.1 +3.8 64+2.1Apoptosis, cis and trans analogues
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Discussion
We have demonstrated the potential of two novel isomeric
platinum analogues JM149 (cis) and JM335 (trans) ammine
(cyclohexylamine)dihydroxodichloroplatinum (IV) (Kelland
1 2 3 4 5 6 7 8 9 10 11 12 13 1415
225 kb '
Figure 7 FIGE of attached and detached cells collected 24h
following a 2h exposure to 2 x , 5 x and l0x IC50 of JM149 and
JM335. Lanes: 1, S. cerevisae standards 225-2200kb; 2 and 15, A
fragments 0.1-200kb; 3-5, JM149 attached cells; 6-8, JM335
attached cells; 9-11, JM149 detached cells; 12-14, JM335
detached cells.
JM149
2 x IC50
JM149
5x IC50
et al., 1994) to induce apoptosis in the CHI human ovarian
carcinoma cell line. This cell line has previously been shown
to be relatively sensitive to cisplatin (e.g. Kelland et al., 1994)
and to undergo apoptosis following exposure to physiologi-
cally relevant concentrations of cisplatin (Ormerod et al.,
1994b, 1996). Following a 2 h exposure to various
concentrations of cisplatin, cells rounded up and detached
from the monolayer in a time- and dose-dependent manner
with the majority of cells detaching at between 24 and 48 h
following removal of drug. Electron and light microscopy
revealed that the detached cells from both CHI cell lines
displayed typical morphological features of apoptosis with
the DNA degraded into fragments of 30-50 kb in size. The
major cell cycle effect appeared to be S-phase slowdown with
a comparatively small G2 block. Studies have shown that
CHI cells possess a wild-type p53 gene sequence, which is
induced approximately 5-fold following 5 Gy gamma-
irradiation (Walton et al., 1996) and express Bcl-2 protein
(Beale et al., 1996).
Both platinum-based isomers induced apoptosis in this cell
line at 2 x IC50, a concentration which is roughly equivalent
to a 95% inhibition of cell growth. The detached cells elicited
by the two drugs exhibited fragmentation and condensation
of chromatin around the periphery of the nuclear membrane
(Figure Sd and e) consistent with the morphology of
apoptosis (Wyllie, 1980; Arends et al., 1990; Arends and
Wyllie 1991). That apoptosis.had indeed occurred was further
substantiated by the presence of a 50 kb DNA fragment
(Walker et al., 1991; Oberhammer et al., 1993; Brown et al.,
1993; Ormerod et al., 1994b and 1996) observed in the
JM335
2 x IC50
JM335
5x IC50
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Figure 8 DNA histograms showing the cell cycle changes with time (h) following a 2 h exposure to 2 x and 5 x IC50 of JM149 and
JM335.
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only in the detached cell population. In striking contrast to
this, the trans isomer JM335 did not induce apoptosis at
10 x IC50. The chromatin of the detached cells remained
normal in appearance with no morphological evidence of
apoptosis having taken place (Figure 5g). Moreover, no
50 kb DNA fragment or fragments of a similar size were
detected on FIGE (Figure 7). Notably, the detached cells
displayed extensive vesiculation of the cytoplasm at this
concentration which was not observed in cells undergoing
apoptosis following the lower dose of this drug. The reason
for this is unclear but may have been due to loss of osmotic
control and subsequent water imbalance. In certain respects
the vesiculation observed with JM335 resembles structures
observed in cells undergoing necrosis following heating to
temperatures of between 42 and 47'C (Harmon et al., 1990),
but in the case of JM335, vesiculation occurred on a greater
scale occupying in some cases almost 50% of cell volume.
Furthermore, very few of these cells displayed the irregular
5 frasmentation t2attern of condensed chromatin associated
Time (h)
0 5 10 15
Time (h)
Figure 9 Percentage number of cells in each I
cycle measured over a 24h period following a
JM149 and JM335. Open symbols, 2 x IC50 and
5xIC50 (G1 O, *) (S A, A) (G2 O, *)-
detached cells induced by both drugs on FIG
many cases the DNA of apoptotic cells is u]
at internucleosomal sites into fragments
multiples thereof (Arends et al., 1990; (
giving a DNA ladder effect on gel ele(
common with our studies with cisplatin, i
degradation was not observed in the apopto
by either JM149 or JM335 in the CHI cell lip
morphological evidence of apoptosis in th
remaining following JM149 (Figure 5b), but
of apoptotic-like cells were identified in ti
population following exposure to JM33
However, none of the attached cells exhibil
of a 50 kb fragment on FIGE, not even
concentrations of both drugs. Thus the leN
seen in the attached cells following JM335
under these experimental conditions to yie
50 kb fragment. Interestingly, cell viability
that around 40% of the detached cells retain(
membranes at 24 h which is comparatively
seen with cisplatin, in which over 60% of det
cells maintained plasma membrane integrity I
1994b).
The cis analogue JM149 induced apoptosis
range of concentrations used (2 x, 5 x ar
evidenced by either change in morphology or
a 50 kb fragment, with features of apoptosis
with cells undergoing necrosis (Harmon et al., 1990; Collins
et al.. 1992) and intriguinglv a higher proportion of these
detached cells (64%) had intact cell membranes at 24 h
compared with the apoptotic cells. This does not, however,
eliminate necrosis as the mode of cell death in these cells.
It can be seen in the detached cell population that while
there was a strong 50 kb band at 2 x IC50 of JM335, this was
less intense at 5XIC50 and undetectable at 1Ox IC50. Great
care was exercised to ensure that equal numbers of cells were
loaded into each well in order to reduce variance in nuclear
material between samples; thus it can be reasonably assumed
that the difference in band intensity seen between 2 x and
5 x IC50 of this drug was entirely due to a smaller number of
cells undergoing apoptosis at the higher concentration. We
conclude, therefore, that the complete absence of 50 kb
fragment and lack of apoptotic morphology indicates that
cell death did not occur through apoptosis at 10 x IC50 of
JM335, with cells dying by an alternative process.
Another striking difference in activity between the two
drugs was that at both 2x and 5x IC50 of JM149, cells
20 25 appear to have experienced a lag phase (approximately 15 h)
to the onset of apoptosis, whereas at 2 x IC50 of JM335 the
phase of the cell rate of induction of apoptosis is almost linear (Figure 4b).
a 2 exposure to Moreover, while at 2 x IC50 of JM149 there was a measurable
closed symbols, increase in the number of attached cells up to 24 h, no
increase in the attached cell population was observed with
either concentration of JM335 (Figure 4a). However, at 24 h
after drug incubation the combined totals for attached and
IE (Figure 7). In detached cells were similar for each concentration of both
Itimately cleaved JM149 and JM335. Thus it is possible that following
of 180 bp and exposure to JM335, cells underwent aberrant division and
-ompton, 1992) the dividing cells detached immediately thereafter. Other
ctrophoresis. In studies have shown that drugs of disparate structures and
internucleosomal mechanisms of action display a differential time lag to the
)tic cells induced induction of apoptosis and that there are differences in the
le. There was no way various agents ultimately induce apoptosis (Wood et al.,
e attached cells 1995). However, JM149 and JM335 differ only in the
a small number orientation of a chlorine and ammine group around a
he attached cell central Pt. Nonetheless, JM335 induced apoptosis at a much
5 (Figure 5c). greater rate than JM149, such that at 2 x IC50 of both drugs
ted the presence over four times as many cells had undergone apoptosis by
at the highest 24 h with the trans compound. In addition, this concentration
vel of apoptosis of JM335 induced apoptosis at a faster rate than 5 x IC50 Of
was insufficient JM149.
,ld a detectable Interestingly, the more rapid kinetics of apoptosis seen
studies showed with JM335 does not appear to be related to the amount of
ed intact plasma total Pt binding to DNA. While at equimolar concentrations
lower than that this is 2-fold higher for JM335 compared with JM149
tached apoptotic (approximately 110 and 50 pmol mg-' DNA respectively at
(Ormerod et al., 50,M), at equitoxic concentrations of both drugs the levels
of Pt bound to DNA are similar (80 vs 70 pmol Pt mg-
across the wide DNA at 2 x IC50). Thus the more rapid induction of
id 10 x IC50) as apoptosis by JM335 may relate to differences in the nature
the presence of of DNA damage induced by the two isomers in this cell line.
being observed Notably, JM335, but not JM149, was shown to induce DNA
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strand breaks in the CH1 cells following 2-4 h drug
exposure to 25 and 100 gM (Mellish et al., 1995). In
contrast, Pt-DNA interstrand cross-links were measurable
in CHl cells following exposure to JM149 (25 or
100 pmx 4 h), but not with JM335. Moreover, the nature
of intrastrand cross-links induced by the two drugs appear to
differ; a monoclonal antibody raised against cisplatin-treated
DNA (and thought to recognise the major 1,2 G-G
intrastrand adduct induced by cisplatin) recognised DNA
adducts in CHl cells produced by JM149 exposure but not
by JM335 (Mellish et al., 1995). These comparative DNA-
binding properties suggest that the slower rate ofinduction of
apoptosis with the cis complex JM149, may relate to a
requirement for the conversion ofcross-links to strand breaks
in order to generate an apoptotic response. This may be at
least partially addressed through investigations ofp53 protein
induction in this cell line by these two drugs.
Other observations made in freshly isolated rat thymocytes
showed that, in contrast to agents such as etoposide which
directly induce DNA strand breaks and which readily
induced apoptosis, cisplatin-induced apoptosis may need to
be coupled to a cell cycle-mediated event (Evans and Dive,
1993). Thus this may also apply for JM149 but not for
JM335 (which induces strand breaks directly in this line).
A recent study has shown that B-cell human lymphoma
cells which underwent apoptosis at comparatively low
concentrations of idarubicin and doxorubicin failed to do
so at higher concentrations of these drugs (Smith et al.,
1994). It was proposed that, at high concentrations ofdrug, a
failure to traverse S-phase was associated with the failure of
these cells to engage the process of apoptosis. Previous
studies from our group have shown that the main cell cycle
effect of cisplatin on CH1 cells was a slowdown in S-phase
transit with apoptosis occurring predominantly, although not
exclusively, from this phase of the cell cycle (Ormerod et al.,
1996). Other investigations have shown that cisplatin induces
apoptosis in all phases of the cell cycle in some cell types
(HL-60 cells) (Gorczyca et al., 1993). Our observations show
that the cell cycle effects ofJM149 and JM335 were similar to
those observed with cisplatin in that the main feature was a
slowdown in the passage of cells through S-phase. By 24 h
cells were detained in either early S-phase (2 x and 5 x IC50 Of
JM335 and JM149 respectively) or late S-phase (2 x IC50
JM149) (Figure 8). There was no evidence of a G2/M block at
24 h at these concentrations and therefore it is likely that
apoptosis occurred mainly from cells in S-phase. On the other
hand, following exposure of the CHI cell line to 5 x IC50 Of
JM335, cells appeared almost frozen in the cell cycle with
evidence of a build-up of cells in G2 indicative of a G2/M
block. The DNA histograms in Figure 8 give the impression
that the majority of cells were prevented from cycling and
were dying from all phases of the cell cycle. Thus the inability
ofthese cells to progress effectively from one phase of the cell
cycle to another at this concentration of JM335 may be the
reason for their failure to engage apoptosis.
In conclusion we have shown that JM149 and JM335
induced apoptosis in the CHI cell line at equitoxic and
physiologically relevant concentrations of drug and that the
kinetics of apoptosis was more rapid with the trans
compound JM335. This may relate to differences in DNA
adduct formation by these two isomers. However, at high
concentrations (10 x IC50) of JM335, CHI cells fail to
undergo apoptosis and cell death occurs by an alternative
method.
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